 The investigators hypothesize that, among non-hypertensive overweight and obese individuals, treatment of vitamin D deficiency and lowering uric acid concentrations by either xanthine oxidase inhibition or increased renal excretion will attenuate renin angiotensin system RAS activation, improve endothelial function, and lower blood pressure. 